{"@id":"https://bioecon.ru/technology/in-vivo-car-t-generation/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://bioecon.ru/technology/in-vivo-car-t-generation/","json":"https://bioecon.ru/api/v1/technology/in-vivo-car-t-generation/index.json"},"id":"in-vivo-car-t-generation","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/impextraco/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/host-group/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/biobichos-ltda/","https://bioecon.ru/companies/allozymes/","https://bioecon.ru/companies/naturmega/","https://bioecon.ru/companies/brevel/","https://bioecon.ru/companies/checkerspot/"]},"maturity":7,"name":"Генерация CAR-T-клеток in vivo","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Таргетирование поверхности Т-клеток"},{"n":2,"title":"Исключение печеночного клиренса"},{"n":3,"title":"Транзиентная или интегративная экспрессия"},{"n":4,"title":"Стимуляция цитокинами in vivo"}],"summary":"Введение готовых таргетных вирусных или нанолипидных векторов, избирательно трансдуцирующих и программирующих Т-лимфоциты непосредственно в сосудистом русле пациента.","url":"/technology/in-vivo-car-t-generation/","verified":"2026-11-22"}